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FoldingWhether Cyclophilin A (CyPA) functions as a foldase or a chaperone when assisting protein folding
has long been argued. In this study, we engineered four variants of recombinant human Cyclophilin
A (rhCyPA), all of which were inactive to tetrapeptide substrate Suc-AAPF-pNA. However, these vari-
ants were able to suppress aggregation during arginine kinase (AK) refolding as efﬁcient as wild-
type rhCyPA, especially, variant Q63A had even more efﬁciency to suppress aggregation and improve
reactivation yields of AK. These results indicate that rhCyPA have peptidyl–prolyl cis–trans isomer-
ase (PPIase) independent chaperone-like activity during AK folding. In addition, results suggest that
surface hydrophobicity of rhCyPA can suppress AK aggregation and binding to rhCyPA hydrophobic
active pocket is a prerequisite for chaperoning AK folding.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The process of protein folding can be assisted by molecular
chaperones and foldases. The foldases include protein disulﬁde
isomerases (PDIs) and cis–trans isomerases (PPIases); these en-
zymes catalyse the rearrangement of disulﬁde bonds and the cis–
trans isomerisation of peptidylprolyl bonds, respectively [1–3].
To date, the study of human CyPAmainly involves its role in viral
infection and replication [4–6]. However, the chaperone function of
CyPA has attracted the interest of many investigators for several
decades. The single-domain CyPA has long been known to function
as a PPIase and was proposed to function as a chaperone [7]. More
recently, several multidomain PPIases have been found to act as
both PPIases and chaperones [8–10]. However, the chaperone func-
tion of CypA has long been argued because some researchers sug-
gest that the single-domain CyPA only acts as an isomerase
during protein folding [11,12]. The focus of this controversial opin-
ion is whether CyPA play a PPIase or a chaperone role during pro-
tein folding. To eliminate the interference of its PPIase activity
during protein folding, a CyPA enzyme without PPIase activitywas constructed and used to test the chaperone activity. Ou et al.
observed that the inactive porcine kidney CypA, as well as an active
PPIase, could improve the reactivation of denatured creatine kinase
and prevent its aggregation during folding, which indicates that
CypA has a chaperone function [13]. Chakraborty et al. demon-
strated that the N-terminal-truncated form (N22-88DEL) of
Leishmania donovani CyP18 can reactivate the enzyme activity of
the Leishmania donovani adenosine kinase through the disaggrega-
tion of its oligomers [14] and prevent the aggregation of adenosine
kinase both in vitro and vivo [15]. Recently, the controversy of
whether CyPA has the ability to chaperone HCA II, which is the ﬁrst
substrate that is suggested to be chaperone-assisted by CypA, ap-
pears to be deﬁnitely resolved [16]. However, to demonstrate that
this chaperone function is a general property of CyPA, it is very
important to show that CyPA has the ability to chaperone other pro-
teins as well. In this work, we show that another protein (AK) is
chaperoned by rhCyPA.
In previous research studies, we found that two equilibrium
intermediates accompanied the cis–trans prolyl isomerisation that
occurs during the folding of AK, which was obtained from the mus-
cle of shrimp (Fenneropenaeus chinensis) [17]. We have also inves-
tigated the reactivation of denatured AK in the presence of small
artiﬁcial molecular chaperones, such as Triton X-100 and Tween
20 [18]. Moreover, our investigation of the effect of rhCyPA during
AK folding revealed that rhCyPA could form dimers and trimers
during the puriﬁcation procedure [19]. To provide additional
evidence that demonstrate whether the single-domain CyPA acts
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model protein that contains 13 proline residues; the folding of this
protein involves prolyl cis–trans isomerism) as the substrate to
investigate the role of active and inactive PPIases, which were
engineered through the site-directed mutagenesis of the rhCyPA
active sites, during the folding of AK. The results show that rhCyPA
has a chaperone-like function that is independent of its PPIase
function. In addition, we observed that the surface hydrophobicity
of rhCyPA and its variants can suppress the aggregation of AK and
that the binding of AK to the hydrophobic active site of rhCyPA and
its variants is a prerequisite for the chaperoning of AK folding.
2. Materials and methods
2.1. Materials
Suc-AAPF-pNA and triﬂuoroethanol (TFE) were purchased from
Sigma. DEAE-Sepharose Fast Flow and Sephacryl S-100 were ob-
tained from GE. All other chemicals were of analytical grade.
The AK gene from shrimp (Fenneropenaeus chinensis) muscle
was cloned into the PET28a plasmid with a His tag and expressed
in Escherichia coli Rossta. The proteins were puriﬁed by Ni afﬁnity
chromatography. The concentrations of AK were determined
according to the method described by Virden et al. [20].
2.2. Preparation of wild-type and variants
The wild-type rhCyPA, as well as the Q63A, H126A, F60A and
R55A mutants, were engineered through inverse PCR and cloned
into the PQE-60 plasmid, which was subsequently transformed into
the E. coli M15 bacterial strain. The bacterial colonies that were
resistant to both kanamycin and ampicillin were sequenced to en-
sure the ﬁdelity of the mutations. The cells were harvested by cen-
trifugation at 5000 rpm and lysed by ultrasonication at 4 C in a
buffer containing 50 mM Tris–Cl, 1 mM EDTA, 100 mM NaCl,
1 mM phenylmethylsulfonyl ﬂuoride (PMSF) pH 8.0 and 10 mM
b-mercaptoethanol. After the cell debris was discarded by centrifu-
gation (12000 rpm, 20 min, 4 C), 40 ml of the supernatant was
loaded onto the Sephacryl S-100 column (2.6  100 cm). The mate-
rial was then eluted with a buffer containing 20 mM Tris–Cl pH 7.8,
1 mM EDTA, 1 mM PMSF and 10 mM b-mercaptoethanol. The frac-
tions that contained rhCyPA were pooled and loaded onto a DEAE-
Sepharose column. The elution buffer was the same as that used for
the Sephacryl S-100 column, with the exception that it did not con-
tain EDTA and PMSF. The ﬂow-through fractions were analysed by
SDS–PAGE, and the homogenous rhCyPA proteins were combined
and concentrated in a dialysis bag by polyethylene glycol (PEG).
2.3. Fluorescence spectroscopy measurements
The wild-type CyPA and the CyPA variants all had a concentra-
tion of 150 lM. For the spectroscopy experiments, the PPIase was
diluted 10-fold. The ﬂuorescence emission spectrum was mea-
sured using a Hitachi F-4500 spectroﬂuorometer at 20 C.
The ANS ﬂuorescence measurements were performed using slit
widths for the excitation and emission of 5 and 10 nm, respec-
tively. The excitation was measured at a wavelength of 380 nm,
the emission was recorded between 400 and 600 nm.
The intrinsic ﬂuorescence measurements were performed using
a slit width of 5 nm. After excitation at 295 nm, the emission spec-
trum between 300 and 400 nm was monitored.
2.4. Prolyl isomerase activity assay
An improved spectrophotometric assay [21] was used in this
experiment. The stock solution of a-chymotrypsin was dissolvedin 1 mM HCl to a concentration of 10 mg/ml, and the Suc-AAPF-
pNA substrate was prepared and stocked in TFE with 470 mM LiCl
at a concentration of 3.75 mM. For the PPIase inhibition assays,
1 mM of cyclosporin A (CsA) was dissolved in ethanol and
incubated with PPIase for at least 2 min prior to the initiation
of the assay. The activity assay mixture consisted of 430 ll of
50 mM HEPES buffer (containing 100 mM NaCl, pH 8.0), 50 ll of
the a-chymotrypsin stock solution and 10 ll PPIase (to a ﬁnal
concentrations of less than 10 nM; or PPIase-CsA at a PPIase-
to-CsA ratio of approximately 1:2). After a 5-min pre-incubation
of the mixture at 10 C, the activity assay was initiated through
the addition of 10 ll of the Suc-AAPF-pNA solution. The absor-
bance was recorded at 390 nm by an Ultrospec 4300 spectrometer
every 2 s (the last time point tested was 4 min).
Since the assay concentration of the substrate Suc-AAPF-pNA
was much lower than Michaelis constant Km [21], the Michaelis–
Menten velocity equation can be simpliﬁed to V = Vmax [S]/Km = kcat
[E][S]/Km = kobs[E], where kobs = kcat/Km[S]. Because [E] and [S] are
known, the kobs value can be transformed to kcat/Km value, which
can be used to characterize the catalytic activity. The kcat/Km values
of the rhCyPA variants were obtained using the same procedure.
2.5. Folding experiments
The AK protein (at a concentration of 150 lM) was denatured in
3.0 M GuHCl for 1 h at room temperature. The refolding reaction of
AK was then initiated by a 50-fold dilution (to a ﬁnal concentration
of 3 lM) of the AK solution in 20 mM Tris–Cl (containing 10 mM
b-mercaptoethanol, pH 7.8) at 20 C in the absence or presence
of PPIase (ﬁnal concentration of 6 lM) and the addition of CsA to
a concentration of 12 lM (when applicable). The optimal ratio of
denatured AK and wild-type rhCyPA was 1:2. Under this condition,
the highest amount of aggregation suppression could be attained;
thus, this ratio was maintained in all of the folding experiments.
The AK aggregation was followed by monitoring the turbidity at
400 nm using an Ultrospec 4300 spectrometer every 2 s for
3 min. Immediately after the dilution, aliquots (20 ll) were col-
lected at suitable time intervals to determine the AK activity in
the presence and absence of PPIase, according to the protocol de-
scribed by Yu et al. [22]. To calculate the relative refolding yields,
the activity of the native AK, which was treated in the same man-
ner as the refolding sample but without denaturation, was as-
sumed to be 100%. All of the folding experiments were repeated
at least three times. The kinetic data were best ﬁtted by a two-
exponential equation:
y ¼ A1ð1 expðk1tÞÞ þ A2ð1 expðk2tÞÞ
where y is the percent refolding yield, t denotes the time in min, A1
and A2 denote the amplitudes of the ﬁrst and second phases, respec-
tively, k1 and k2 are the rate constants of the ﬁrst and second
phases, respectively. During the process, a dead time of 7 s was
set from the onset of the folding to the recording of the ﬁrst data;
thus, any phase that is shorter than the dead time cannot be de-
tected by these UV measurements.
3. Results
3.1. Variant Q63A has more exposed hydrophobic surface
Fluorescence spectroscopy is often used to characterise the
changes that occur in macromolecular structures, such as proteins
or nucleic acids [23,24]. Because ANS can bind with the hydropho-
bic surface of proteins, which markedly enhances the intensity of
the ﬂuorescence [25], it can often be used to detect the solvent-
exposed states of proteins and other biomacromolecules with a
hydrophobic surface. As shown in Fig. 1A, a higher amount of
Fig. 2. Chymotrypsin-coupled PPIase activity assay with various concentrations of
wild-type rhCyPA. 1–6 represents 0, 0.25, 0.75, 1.50, 3.50, 7.5 nM wild-type,
respectively.
Fig. 3. Values of the kobs rate constants for different concentrations of the wild-type
rhCyPA.
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phobic area is exposed in this variant than in the wild-type or the
other variants. In addition, the intensity of the intrinsic ﬂuores-
cence of the Q63A variant is lower than that of the other variants
and the wild-type (Fig. 1B), which suggests that the Trp in this var-
iant is more efﬁciently quenched by the solvent. In agreement with
the ANS data, our ﬁndings indicate that the Q63A mutation caused
the formation of a looser structure compared with the other vari-
ants/wild-type.
3.2. Prolyl isomerase activity of the mutants retained about less than
0.2% of the wild-type rhCyPA
The argument of whether the single-domain CyPA has PPIase
activity or chaperone activity during its assistance of the protein
folding process began with the ﬁrst report that demonstrated that
CyPA functioned as a chaperone during the refolding of human car-
bonic anhydrase II. To eliminate the effect of PPIase activity, four
variants were constructed. In this work, we selected to experimen-
tally test three active site residues (R55, F60 and H126), which
were shown to play an active role in the active site by Zydowsky
et al. [26], and an additional active site residue (Q63), which was
simulated through hybrid MM/QM by Li and Cui [27].
The results of the chymotrypsin-coupled PPIase activity assay
for various amounts of the wild-type rhCyPA are shown in Fig. 2
and kcat/Km was calculated from the kobs-values from Fig. 3. The
kcat/Km values of the variants were obtained following the same
procedure.
The kcat/Km values of the wild-type and the variants are
shown in Table 1. The wild-type rhCyPA has a kcat/Km value of
1.38  107 M1 s1 at 10 C, which is close to the value reported
in previous studies [21,26,28]. The kcat/Km values of the variants
are all less than 0.2% of the kcat/Km value of the wild-type, which
is in agreement with the data published by Zydowsky et al. [26].
Therefore, the four mutated residues, including Q63, are active-site
residues, and the variants are completely inactive.
3.3. Variant Q63A can suppress aggregation and improve reactivation
yield more efﬁciently than wild-type rhCyPA during AK folding
To compare the abilities of the wild-type and the variants to
prevent aggregation during the protein folding process, we used
denatured AK, which contains 13 prolines [29], as the substrate
protein. Interestingly, as shown in Fig. 4, all of the turbidity curves
obtained in the presence or absence of rhCyPA (or its mutants) are
very similar. However, the start and end points are apparently low-
er than those obtained during the spontaneous folding that occursFig. 1. ANS ﬂuorescence emission and intrinsic ﬂuorescence emission spectra of variants
type, R55A, F60A, H126A and Q63A, respectively. (B) Intrinsic ﬂuorescence emission spewhen rhCyPA or its variants are added. Since rhCypA or its variants
do not signiﬁcantly contribute to the absorbance at 400 nm, the
background turbidity that is induced by the PPIase protein can
be considered negligible. All of this evidence imply that theand wild-type rhCyPA. (A) ANS ﬂuorescence emission spectra, 1–5 represents wild-
ctra, 1–5 represents Q63A, wild-type, H126A, F60A, and R55A, respectively.
Table 1
Kinetic constants of the WT and its variants.
CyP kcat/Km (104) s1 M1
Wild-type 1380.00
R55A 1.17
F60A 1.96
Q63A 1.10
H126A 2.27
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ates of AK during the dead time and that this binding signiﬁcantly
weakens the aggregation that occurs during the initial folding
steps.
The folding kinetics (turbidity curves) of AK in the presence of
any of the inactive variants closely follow the kinetics observed
in the presence of the active wild-type. However, compared with
the wild-type, the Q63A variant more efﬁciently suppresses AK
aggregation (Fig. 4) and improves the AK reactivation yield
(Fig. 6). Coincidently, the global structure of the Q63A variant
makes this variant more solvent-exposed than the other three vari-
ants and the wild-type rhCyPA. It is likely that the increased
amount of exposed hydrophobic surface offers more accessibility
for interaction with the folding intermediates of the AK folding
process; these results are in agreement with those reported by
Chakraborty et al. [14].
3.4. Surface hydrophobicity of rhCyPA prevents the aggregation and
hydrophobic pocket may contribute to the reactivation of AK
Cyclosporin A (CsA), which is a high-afﬁnity inhibitor that binds
to CyPA, was used to block the PPIase activity of CyPA. The
concentration of AK during the refolding was 3 lM, and theFig. 4. Suppression of AK aggregation by wild-type rhCyPA and its variants during refold
GuHCl for 1 h at room temperature. The refolding was initiated by a 50-fold dilution in 2
or absence of 6 lM of the wild-type rhCyPA or its variants at 20 C. The squares, circles, a
PPIase, 6 lM wild-type and 6 lM of the variants (A, R55A; B, F60A; C, Q63A; D, H126A)concentrations of the wild-type and the Q63A variant were 6 lM.
The PPIase was incubated with CsA at a ratio of 1:2 for 12 h before
it was added to the refolding system. To calculate the relative
refolding yields, the activity of the native AK, which was treated
in the same manner as the refolding sample but without denatur-
ation, was assumed to be 100%. In addition, the addition of the PPI-
ase inhibitor CsA to the folding system had negligible inﬂuence on
the aggregation suppression (Fig. 5). Interestingly, as shown in
Fig. 5, the kinetic curves of the aggregation suppression induced
by the wild-type and the Q63A variant were almost identical to
the respective curves obtained in the presence of CsA. In addition,
because CsA is a competitive inhibitor [26] for CyPA, it must bind
to the active pocket, which may block the access of the AK interme-
diates to the hydrophobic pocket of CyPA. These data altogether
indicate that the binding of the substrate to the active hydrophobic
pocket is not a prerequisite for the suppression of aggregation.
The reactivation kinetics of AK showed that the AK recovery
activities of the Q63A variant and the wild-type rhCyPA were on
average 14% and 10% higher, respectively, compared with the
kinetics obtained in the absence of PPIase. However, once the ac-
tive pocket was occupied by CsA, both the wild-type and the
Q63A variant lost their chaperone function during the folding of
AK. These results indicate that the reactivation of the AK folding
intermediates must occur in the pocket, which is consistent with
the data obtained in a previous study [30].
4. Discussion
Chaperones were originally described by their ability to prevent
the aggregation of protein substrates by binding to the non-native
early folding intermediates and helping these molecules reach a
functional conformation [31]. In fact, the prevention or suppression
of aggregation and the enhancement of activity recovery during theing. The AK protein, at an original concentration of 150 lM, was denatured in 3.0 M
0 mM Tris–Cl buffer (pH 7.8, containing 10 mM b-mercaptoethanol) in the presence
nd triangles represent the aggregation during AK refolding in the presence of 0 lM
, respectively.
Fig. 6. Time course of the reactivation of unfolded AK in the presence and absence
of the wild-type rhCyPA or its variants. The data were analysed according to the
protocol described in Materials and methods (Section 2.5). To calculate the relative
refolding yields, the activity of the native AK, which was treated in the same
manner as the refolding sample but without denaturation, was assumed to be 100%.
The following conditions were assayed: Q63A (circle), wild-type rhCyPA (up
triangle), Q63A + CsA (down triangle), wild-type rhCyPA + CsA (left triangle),
without wild-type rhCyPA or the variants (square), CsA (right triangle). During
refolding, the ﬁnal concentrations of AK and CyPA were 3 and 6 lM, respectively.
Fig. 5. Suppression of AK aggregation by PPIase and CsA. During refolding, the ﬁnal
concentrations of AK and PPIase were 3 and 6 lM, respectively. CsA was incubated
with PPIase overnight to ensure adequate binding prior to the initiation of the
folding process. The following conditions were assayed: CsA (right triangle),
without wild-type rhCyPA or the variants (square), wild-type rhCyPA (circle), wild-
type rhCyPA + CsA (down triangle), Q63A (up triangle), Q63A + CsA (left triangle).
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was regarded as the most important step of the chaperone-
facilitated protein folding process. Several chaperones were thus
reported, among which CyPA was considered to be one of the
candidates [7,13]. However, the original report on the chaperone
function of CyPA [7] was doubted because some researchers
believed that only the enzymatic activity of the PPIase played an
important role during HCA II refolding [11]. A later report by Ou
et al. showed the efﬁciency of inactive CyPA in the chaperoning of
the creatine kinase folding process. However, oxidization or other
indeﬁnite factors that lead to the loss of PPIase activity during the
preservation of CyPA likely induces a stereospeciﬁc blockade that
may affect the interaction of CyPA and the protein substrate. To
resolve these problems and provide more useful evidence that
support or disprove the chaperone activity of CyPA, four variants
(Arg55A, F60A, Q63A and H126A) were constructed throughsite-directedmutagenesis, and the corresponding proteinswere ex-
pressed and puriﬁed to homogeneity by SDS–PAGE. The protease-
coupled assay for the analysis of prolyl isomerase activity showed
that the variants are almost inactive compared to the wild-type.
The structures of the variants were characterised by ANS ﬂuo-
rescence spectrometry and intrinsic ﬂuorescence spectrometry.
The ANS ﬂuorescence spectra and the intrinsic ﬂuorescence spectra
all indicate that the Q63A variant is more solvent-exposed than the
other variants and the wild-type (Fig. 1). By comparing the ability
of the variants and the wild-type to suppress aggregation during
AK refolding, we found that the aggregation-suppressing ability
of the variants is similar to that of the wild-type (Fig. 4). Interest-
ingly, the Q63A variant was more efﬁcient than the wild-type in
the suppression of AK aggregation; since the Q63A variant has
the loosest spatial structure, the higher efﬁciency of this variant
in the suppression of protein aggregation may be due to the expo-
sure of a higher amount of hydrophobic residues. Similar mecha-
nisms have been proposed to explain why a truncated Leishmania
donovani CyPA is more efﬁcient than the full-length CyPA in the
reactivation of adenosine kinase [14].
The results (Fig. 4) show that the slopes of the turbidity curves
obtained in the presence or absence of rhCypA (or its mutants)
have apparent absorption at 400 nm within the 7-s dead time;
these results indicate that the folding intermediates emerged and
rapidly formed considerable aggregates (Fig. 7). The curves re-
corded after the dead time are equally steep, regardless of the pres-
ence of rhCyPA. However, the aggregation is markedly suppressed
within the dead time. All of these results imply that rhCyPA and its
variants can only exert a chaperone effect by binding to the early
intermediates of the AK folding process but cannot dissociate the
formed aggregates (Fig. 7). This result is in agreement with the ac-
tion of the chaperone GroE, which is only active during the early
steps of protein folding and cannot rescue the insoluble aggregated
proteins [32].
In addition, rhCyPA and its variants can block protein aggrega-
tion during AK folding even in the presence of its inhibitor CsA
(Fig. 5). However, once the active pocket binds to CsA, rhCyPA
and its variants completely lose their ability to improve AK reacti-
vation (Fig. 6). Although the molecular determinants of CyPA for
CsA binding may not be identical to the molecular determinants
for protein substrates [33], the CsA binding may induce a stereo-
speciﬁc blockade that blocks the access of the AK intermediates
to the hydrophobic pocket of rhCyPA. This evidence indicate that
the hydrophobicity of rhCyPA and its variants may exert inﬂuence
on the folding yields in two ways: the surface hydrophobicity pre-
vents the aggregation that is caused by the hydrophobic interac-
tion of AK proteins (Fig. 7), which is consistent with the data
published in other reports [14,34], and the binding of the substrate
to the hydrophobic active pocket is a prerequisite of native folding
(Fig. 7). Moreover, the Q63A variant improved the AK reactivation
yields more effectively than the wild-type CyPA.
The folding kinetic curves showed that the aggregation reached
an equilibrium quickly (within 3 min) (Fig. 4) and that the activity
recovery was signiﬁcantly delayed (Fig. 6). These results indicate
that the AK refolding process involves the rapid production of an
early folding intermediate (like-native) and a signiﬁcantly slow
rearrangement course (native) (Fig. 7). This result is in agreement
with the data published by Freskgard et al. [7].
Recently, Moparthi et al. [30] and Dorothy Kern’s group [35] re-
ported that rhCypA with active site mutations show similar kinet-
ics compared to wild-type when catalyzing the folding of protein
substrates. They suggested that the active sites mutants of rhCyPA,
although having no PPIase activity for the tetrapeptide substrate
Suc-AAPF-pNA, still played a role in catalyzing proline isomeriza-
tion during protein folding. Because molecular chaperones typi-
cally increase the yield but not the rate of folding reactions [32],
Fig. 7. Schematic representation of the AK folding process chaperoned by rhCyPA. A, aggregated state; D, denatured state; I1 and I2, folding intermediates; N, native state; P,
proline. Through binding to the aggregation-prone intermediate I1, the rhCyPA surface hydrophobicity lowers the concentration of this intermediate and minimises the
formation of the aggregates (A). After the slow rearrangement of the protein inside the hydrophobic pocket of rhCyPA is completed, the intermediate like-native (I2) is folded
into its native state (N).
X.-C. Zhang et al. / FEBS Letters 587 (2013) 666–672 671the improved AK reactivation yields were mainly due to the rhCy-
PA chaperone-like function but not its isomerisation activity.
To conclude, the rhCyPA has a chaperone-like function, which is
independent of its PPIase activity for the tetrapeptide substrate
substrate Suc-AAPF-pNA, and the power of this function is associ-
ated with its surface hydrophobicity and the accessibility of its ac-
tive pocket. In addition, we showed that the folding process of AK,
which is a model protein that contains 13 proline residues and pro-
lyl cis–trans isomerism in the folding process, is chaperoned by
rhCyPA. This ﬁnding is essential for understanding the general
roles that CyPA plays in the cell.
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